title: Sol-gel-based biosensing applied to medicinal science.
abstract: Biosensors have opened new horizons in biomedical analysis, by ensuring increased assay speed and flexibility, and allowing point-of-care applications, multi-target analyses, automation and reduced costs of testing. This has been a result of many studies merging nanotechnology with biochemistry over the years, thereby enabling the creation of more suitable environments to biological receptors and their substitution by synthetic analogue materials. Sol-gel chemistry, among other materials, is deeply involved in this process. Sol-gel processing allows the immobilization of organic molecules, biomacromolecules and cells maintaining their properties and activities, permitting their integration into different transduction devices, of electrochemical or optical nature, for single or multiple analyses. Sol-gel also allows to the production of synthetic materials mimicking the activity of natural receptors, while bringing advantages, mostly in terms of cost and stability. Moreover, the biocompatibility of sol-gel materials structures of biological nature allowed the use of these materials in emerging in vivo applications. In this chapter, biosensors for biomedical applications based on sol-gel derived composites are presented, compared and described, along with current emerging applications in vivo, concerning drug delivery or biomaterials. Sol-gel materials are shown as a promising tool for current, emerging and future medical applications.
authors.forename: Felismina T C
authors.initials: FT
authors.lastname: Moreira
authors.forename: Ana P
authors.initials: AP
authors.lastname: Moreira-Tavares
authors.affiliation: BioMark Sensor Research, Instituto Superior de Engenharia do Porto, R. Dr. Antonio Bernardino de Almeida, 431, 4200-072 Porto, Portugal. goreti.sales@gmail.com.
authors.forename: M Goreti F
authors.initials: MG
authors.lastname: Sales
mesh_terms: D000818:Animals; D055910:Antibodies, Immobilized / Q000737:chemistry*; D015374:Biosensing Techniques / Q000379:methods*; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D004337:Drug Carriers / Q000138:chemical synthesis / Q000737:chemistry; D004339:Drug Compounding / Q000379:methods; D005782:Gels; D006801:Humans; D054802:Molecular Imprinting / Q000379:methods*; D044367:Phase Transition; D016062:Porosity; D062165:Receptors, Artificial / Q000138:chemical synthesis / Q000737:chemistry; D023822:Tissue Engineering
chemical_list: D055910:Antibodies, Immobilized; D004337:Drug Carriers; D005782:Gels; D062165:Receptors, Artificial